Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent Melanoma
Clinical trial NCT00002892 · COMPLETED
Trial details
- NCT number
- NCT00002892
- Sponsor
- Institute of Cancer Research, United Kingdom
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1995-10-01
- Enrollment
- 1000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.